Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 46 | 2024 | 5251 | 3.840 |
Why?
|
Lung Neoplasms | 65 | 2024 | 13262 | 3.550 |
Why?
|
Radiosurgery | 22 | 2024 | 1343 | 3.260 |
Why?
|
Radiation Oncology | 6 | 2023 | 563 | 2.150 |
Why?
|
Radiation Pneumonitis | 5 | 2024 | 102 | 1.520 |
Why?
|
Artificial Intelligence | 10 | 2024 | 2557 | 1.470 |
Why?
|
Radiation Injuries | 3 | 2023 | 1183 | 1.240 |
Why?
|
Radiotherapy | 6 | 2019 | 1504 | 1.130 |
Why?
|
Cone-Beam Computed Tomography | 3 | 2020 | 471 | 0.990 |
Why?
|
Tachycardia, Ventricular | 7 | 2022 | 1303 | 0.960 |
Why?
|
Heart Diseases | 3 | 2022 | 2809 | 0.880 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 11 | 2024 | 1660 | 0.870 |
Why?
|
Radiation Dosage | 12 | 2022 | 1958 | 0.810 |
Why?
|
Tumor Burden | 9 | 2020 | 1895 | 0.770 |
Why?
|
Thoracic Neoplasms | 1 | 2023 | 266 | 0.760 |
Why?
|
Coronary Vessels | 5 | 2022 | 3112 | 0.610 |
Why?
|
Collagen Diseases | 1 | 2017 | 39 | 0.590 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2020 | 421 | 0.590 |
Why?
|
Urologic Diseases | 2 | 2018 | 248 | 0.580 |
Why?
|
Equipment and Supplies | 1 | 2020 | 275 | 0.580 |
Why?
|
Equipment Failure | 1 | 2018 | 577 | 0.530 |
Why?
|
Neoplasm Staging | 19 | 2024 | 11152 | 0.520 |
Why?
|
Salvage Therapy | 3 | 2018 | 1268 | 0.510 |
Why?
|
Tomography, X-Ray Computed | 20 | 2024 | 20509 | 0.500 |
Why?
|
Heart | 5 | 2023 | 4393 | 0.470 |
Why?
|
Pneumonectomy | 2 | 2018 | 1111 | 0.450 |
Why?
|
Neoplasms | 10 | 2024 | 22072 | 0.450 |
Why?
|
Peanut Hypersensitivity | 3 | 2022 | 211 | 0.440 |
Why?
|
Humans | 137 | 2024 | 760621 | 0.430 |
Why?
|
Four-Dimensional Computed Tomography | 3 | 2024 | 144 | 0.420 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2943 | 0.420 |
Why?
|
Pacemaker, Artificial | 1 | 2018 | 815 | 0.420 |
Why?
|
Retrospective Studies | 36 | 2024 | 80372 | 0.410 |
Why?
|
Urinary Bladder | 4 | 2014 | 1166 | 0.390 |
Why?
|
Cystectomy | 2 | 2014 | 697 | 0.390 |
Why?
|
Radiotherapy Dosage | 9 | 2024 | 2897 | 0.380 |
Why?
|
Catheter Ablation | 5 | 2022 | 2758 | 0.370 |
Why?
|
Natural Language Processing | 4 | 2023 | 1135 | 0.360 |
Why?
|
Muscle, Smooth | 1 | 2014 | 924 | 0.360 |
Why?
|
Aged | 48 | 2024 | 169152 | 0.360 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2011 | 275 | 0.360 |
Why?
|
Adenocarcinoma | 7 | 2022 | 6315 | 0.350 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2021 | 801 | 0.340 |
Why?
|
Aged, 80 and over | 24 | 2020 | 58995 | 0.330 |
Why?
|
ras Proteins | 1 | 2014 | 1052 | 0.330 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2014 | 2276 | 0.320 |
Why?
|
Vascular Diseases | 1 | 2017 | 1182 | 0.320 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1499 | 0.320 |
Why?
|
Esophageal Neoplasms | 3 | 2023 | 1648 | 0.320 |
Why?
|
Middle Aged | 50 | 2024 | 220352 | 0.310 |
Why?
|
Vulvar Neoplasms | 1 | 2010 | 263 | 0.300 |
Why?
|
Lung | 10 | 2024 | 9994 | 0.290 |
Why?
|
Male | 61 | 2024 | 359744 | 0.290 |
Why?
|
Uremia | 4 | 1992 | 201 | 0.270 |
Why?
|
Combined Modality Therapy | 8 | 2022 | 8552 | 0.260 |
Why?
|
Cardiomyopathies | 3 | 2024 | 1952 | 0.260 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3334 | 0.260 |
Why?
|
Female | 55 | 2024 | 391270 | 0.260 |
Why?
|
Point Mutation | 1 | 2011 | 1594 | 0.250 |
Why?
|
Models, Statistical | 2 | 2019 | 5075 | 0.250 |
Why?
|
Urethra | 2 | 2018 | 406 | 0.250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2024 | 11712 | 0.250 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10344 | 0.240 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2017 | 1728 | 0.240 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7475 | 0.240 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8056 | 0.230 |
Why?
|
Thorax | 2 | 2024 | 553 | 0.220 |
Why?
|
Temporal Muscle | 1 | 2023 | 36 | 0.220 |
Why?
|
Kaplan-Meier Estimate | 6 | 2019 | 6544 | 0.220 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2016 | 2007 | 0.220 |
Why?
|
Hypertension | 2 | 2022 | 8594 | 0.220 |
Why?
|
Growth Charts | 1 | 2023 | 60 | 0.220 |
Why?
|
Carcinoma | 1 | 2014 | 2331 | 0.210 |
Why?
|
Venous Thromboembolism | 1 | 2016 | 1864 | 0.210 |
Why?
|
Mutation | 9 | 2024 | 29932 | 0.210 |
Why?
|
Algorithms | 10 | 2024 | 13981 | 0.210 |
Why?
|
Preoperative Care | 2 | 2011 | 2256 | 0.200 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5325 | 0.200 |
Why?
|
Multivariate Analysis | 6 | 2018 | 12159 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4490 | 0.200 |
Why?
|
Acrylamides | 1 | 2024 | 260 | 0.200 |
Why?
|
Esophagitis | 1 | 2023 | 163 | 0.200 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6659 | 0.200 |
Why?
|
Prostatic Neoplasms | 4 | 2023 | 11345 | 0.200 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2008 | 800 | 0.190 |
Why?
|
Rectal Neoplasms | 1 | 2010 | 1152 | 0.190 |
Why?
|
Survival Analysis | 4 | 2020 | 10182 | 0.190 |
Why?
|
Medical Oncology | 3 | 2023 | 2313 | 0.190 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2018 | 707 | 0.190 |
Why?
|
Automation | 1 | 2023 | 580 | 0.190 |
Why?
|
Adult | 30 | 2024 | 219994 | 0.190 |
Why?
|
Prescriptions | 1 | 2023 | 388 | 0.190 |
Why?
|
Radiation Tolerance | 3 | 2018 | 480 | 0.190 |
Why?
|
Radiopharmaceuticals | 1 | 2011 | 2634 | 0.190 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2016 | 4024 | 0.190 |
Why?
|
Neoadjuvant Therapy | 5 | 2016 | 2821 | 0.180 |
Why?
|
Treatment Outcome | 18 | 2022 | 65017 | 0.180 |
Why?
|
Calcitriol | 2 | 1992 | 297 | 0.180 |
Why?
|
Cefazolin | 1 | 2021 | 94 | 0.180 |
Why?
|
Imaging, Three-Dimensional | 4 | 2014 | 4048 | 0.180 |
Why?
|
Desensitization, Immunologic | 3 | 2022 | 534 | 0.180 |
Why?
|
Ribosomal Proteins | 2 | 2017 | 363 | 0.170 |
Why?
|
Fluoroscopy | 2 | 2014 | 948 | 0.170 |
Why?
|
Prognosis | 10 | 2022 | 29658 | 0.170 |
Why?
|
Indoles | 2 | 2024 | 1829 | 0.160 |
Why?
|
Phantoms, Imaging | 4 | 2022 | 2512 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2024 | 8950 | 0.160 |
Why?
|
Neutrons | 1 | 2018 | 77 | 0.160 |
Why?
|
Sarcoidosis | 1 | 2024 | 520 | 0.150 |
Why?
|
Aniline Compounds | 1 | 2024 | 1069 | 0.150 |
Why?
|
Arrhythmias, Cardiac | 4 | 2023 | 2255 | 0.150 |
Why?
|
Sarcopenia | 1 | 2023 | 372 | 0.150 |
Why?
|
Ablation Techniques | 1 | 2021 | 248 | 0.150 |
Why?
|
Laryngeal Neoplasms | 1 | 2022 | 514 | 0.150 |
Why?
|
Respiration | 5 | 2017 | 1654 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2023 | 9276 | 0.150 |
Why?
|
Pneumonia | 2 | 2020 | 2131 | 0.150 |
Why?
|
Penicillins | 1 | 2021 | 407 | 0.150 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2020 | 262 | 0.150 |
Why?
|
Body Composition | 2 | 2024 | 2419 | 0.150 |
Why?
|
Diagnostic Imaging | 3 | 2019 | 3527 | 0.150 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 549 | 0.150 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39261 | 0.140 |
Why?
|
Pulmonary Veins | 1 | 2023 | 745 | 0.140 |
Why?
|
Larynx | 1 | 2022 | 492 | 0.140 |
Why?
|
Cohort Studies | 7 | 2021 | 41335 | 0.140 |
Why?
|
Angina Pectoris | 1 | 2021 | 969 | 0.140 |
Why?
|
Myocardial Revascularization | 1 | 2021 | 841 | 0.140 |
Why?
|
Survival Rate | 4 | 2018 | 12808 | 0.130 |
Why?
|
Death | 1 | 2021 | 678 | 0.130 |
Why?
|
Carcinoma, Large Cell | 1 | 2016 | 113 | 0.130 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9185 | 0.130 |
Why?
|
Electrophysiology | 1 | 2019 | 1265 | 0.130 |
Why?
|
Antibiotic Prophylaxis | 1 | 2021 | 643 | 0.130 |
Why?
|
Carcinoma in Situ | 1 | 2021 | 796 | 0.130 |
Why?
|
Medical Errors | 1 | 2023 | 1255 | 0.130 |
Why?
|
Cytoplasmic Granules | 1 | 2018 | 573 | 0.120 |
Why?
|
Disease-Free Survival | 3 | 2021 | 6828 | 0.120 |
Why?
|
Ribonucleoproteins | 1 | 2018 | 372 | 0.120 |
Why?
|
Osteopontin | 1 | 2017 | 302 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2023 | 1190 | 0.120 |
Why?
|
Cranial Irradiation | 1 | 2017 | 391 | 0.120 |
Why?
|
Medical Informatics | 1 | 2021 | 732 | 0.120 |
Why?
|
Food Hypersensitivity | 1 | 2022 | 697 | 0.120 |
Why?
|
Immunoconjugates | 1 | 2022 | 949 | 0.120 |
Why?
|
Incidence | 6 | 2021 | 21392 | 0.120 |
Why?
|
Radiotherapy, Conformal | 1 | 2017 | 549 | 0.120 |
Why?
|
Evaluation Studies as Topic | 1 | 2016 | 1628 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 6 | 2024 | 36290 | 0.120 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 2014 | 629 | 0.110 |
Why?
|
Positron-Emission Tomography | 6 | 2019 | 6465 | 0.110 |
Why?
|
Radiometry | 2 | 2017 | 813 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5643 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15789 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2014 | 3618 | 0.110 |
Why?
|
Ribosomes | 1 | 2017 | 501 | 0.110 |
Why?
|
Predictive Value of Tests | 5 | 2018 | 15289 | 0.110 |
Why?
|
Neoplasm Metastasis | 6 | 2022 | 4902 | 0.110 |
Why?
|
Observer Variation | 2 | 2016 | 2601 | 0.110 |
Why?
|
Risk Factors | 11 | 2022 | 74359 | 0.110 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 1116 | 0.110 |
Why?
|
Reproducibility of Results | 8 | 2024 | 20080 | 0.110 |
Why?
|
Lung Diseases | 1 | 2023 | 1915 | 0.110 |
Why?
|
Prostate | 2 | 2023 | 1793 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2023 | 3765 | 0.100 |
Why?
|
Renal Dialysis | 2 | 1992 | 1801 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2015 | 1791 | 0.100 |
Why?
|
GTP-Binding Proteins | 1 | 2017 | 951 | 0.100 |
Why?
|
Thoracic Wall | 1 | 2014 | 199 | 0.100 |
Why?
|
Drug Hypersensitivity | 1 | 2021 | 916 | 0.100 |
Why?
|
Ubiquitination | 1 | 2017 | 1008 | 0.100 |
Why?
|
Administration, Oral | 5 | 2022 | 4035 | 0.100 |
Why?
|
Brain Neoplasms | 4 | 2017 | 8986 | 0.100 |
Why?
|
Ubiquitin | 1 | 2017 | 838 | 0.100 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1215 | 0.100 |
Why?
|
Organs at Risk | 2 | 2024 | 358 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1677 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 911 | 0.090 |
Why?
|
Pattern Recognition, Automated | 2 | 2014 | 994 | 0.090 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2011 | 146 | 0.090 |
Why?
|
Neoplasm Proteins | 3 | 2023 | 3610 | 0.090 |
Why?
|
Ultrasonography, Prenatal | 1 | 2018 | 1745 | 0.090 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2014 | 861 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1398 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2022 | 3811 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12531 | 0.090 |
Why?
|
Cold Temperature | 1 | 2013 | 780 | 0.090 |
Why?
|
Erythroid Precursor Cells | 2 | 2008 | 211 | 0.090 |
Why?
|
Pleural Neoplasms | 1 | 2015 | 609 | 0.090 |
Why?
|
Protein Biosynthesis | 1 | 2017 | 2105 | 0.080 |
Why?
|
Myocardial Ischemia | 1 | 2020 | 2164 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2014 | 1722 | 0.080 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2015 | 3529 | 0.080 |
Why?
|
Insulin | 4 | 1992 | 6597 | 0.080 |
Why?
|
RecQ Helicases | 1 | 2009 | 53 | 0.080 |
Why?
|
Parathyroid Hormone | 3 | 1992 | 1797 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2882 | 0.080 |
Why?
|
Organoplatinum Compounds | 1 | 2010 | 410 | 0.080 |
Why?
|
Allergens | 3 | 2022 | 1402 | 0.080 |
Why?
|
Disease Progression | 4 | 2024 | 13502 | 0.080 |
Why?
|
Hematopoiesis | 2 | 2011 | 2050 | 0.080 |
Why?
|
Mesothelioma | 1 | 2015 | 807 | 0.080 |
Why?
|
E1A-Associated p300 Protein | 1 | 2009 | 123 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5725 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4642 | 0.080 |
Why?
|
SEER Program | 2 | 2010 | 1530 | 0.080 |
Why?
|
Endpoint Determination | 1 | 2011 | 597 | 0.080 |
Why?
|
Spinal Cord Compression | 1 | 2010 | 235 | 0.080 |
Why?
|
Kidney Failure, Chronic | 4 | 1997 | 2471 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3218 | 0.080 |
Why?
|
Carbohydrate Metabolism | 1 | 1989 | 262 | 0.080 |
Why?
|
Time Factors | 5 | 2019 | 40165 | 0.070 |
Why?
|
ROC Curve | 2 | 2017 | 3568 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2916 | 0.070 |
Why?
|
Prospective Studies | 6 | 2023 | 54303 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2825 | 0.070 |
Why?
|
Prostatectomy | 1 | 2016 | 1956 | 0.070 |
Why?
|
Biosensing Techniques | 1 | 2013 | 677 | 0.070 |
Why?
|
Gene Expression Regulation | 4 | 2011 | 11903 | 0.070 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2018 | 1463 | 0.070 |
Why?
|
Chest Pain | 1 | 2014 | 1106 | 0.070 |
Why?
|
Erythroid Cells | 1 | 2008 | 235 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4312 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4107 | 0.070 |
Why?
|
RNA Interference | 3 | 2017 | 2846 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1913 | 0.060 |
Why?
|
Fluorouracil | 1 | 2010 | 1631 | 0.060 |
Why?
|
Acute Disease | 1 | 2016 | 7269 | 0.060 |
Why?
|
Vitamin D Deficiency | 2 | 1992 | 1379 | 0.060 |
Why?
|
Cell Differentiation | 5 | 2010 | 11481 | 0.060 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2010 | 772 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5351 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2016 | 3486 | 0.060 |
Why?
|
Radiography, Thoracic | 2 | 2023 | 1296 | 0.060 |
Why?
|
Cisplatin | 1 | 2010 | 1644 | 0.060 |
Why?
|
Cytoplasm | 1 | 2009 | 1516 | 0.060 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2005 | 136 | 0.060 |
Why?
|
Postoperative Care | 1 | 2010 | 1479 | 0.060 |
Why?
|
Erythropoiesis | 1 | 2008 | 682 | 0.060 |
Why?
|
United States | 3 | 2022 | 72461 | 0.060 |
Why?
|
Megakaryocytes | 1 | 2008 | 565 | 0.060 |
Why?
|
Heart Aneurysm | 1 | 2024 | 115 | 0.060 |
Why?
|
Spinal Neoplasms | 1 | 2010 | 716 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 4938 | 0.060 |
Why?
|
Insulin Resistance | 3 | 1992 | 3959 | 0.060 |
Why?
|
Phenotype | 3 | 2017 | 16546 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2017 | 12766 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3836 | 0.050 |
Why?
|
Odds Ratio | 2 | 2014 | 9716 | 0.050 |
Why?
|
Silver | 1 | 2023 | 120 | 0.050 |
Why?
|
Glucose | 2 | 1992 | 4351 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7408 | 0.050 |
Why?
|
Thalidomide | 1 | 2008 | 884 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4899 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8515 | 0.050 |
Why?
|
DNA Repair | 1 | 2011 | 2039 | 0.050 |
Why?
|
Area Under Curve | 2 | 2016 | 1636 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1741 | 0.050 |
Why?
|
Hospitals, Teaching | 2 | 2021 | 1166 | 0.050 |
Why?
|
Cystitis | 1 | 2002 | 96 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2008 | 1354 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 198 | 0.050 |
Why?
|
Particle Accelerators | 1 | 2022 | 174 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12626 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15840 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2895 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1974 | 0.050 |
Why?
|
Regression Analysis | 1 | 2010 | 6360 | 0.050 |
Why?
|
Motion | 2 | 2014 | 779 | 0.050 |
Why?
|
British Columbia | 1 | 2021 | 240 | 0.050 |
Why?
|
Clindamycin | 1 | 2021 | 140 | 0.050 |
Why?
|
Nomograms | 1 | 2022 | 238 | 0.050 |
Why?
|
MicroRNAs | 2 | 2008 | 3790 | 0.050 |
Why?
|
Principal Component Analysis | 2 | 2014 | 940 | 0.040 |
Why?
|
Melanoma | 1 | 2019 | 5697 | 0.040 |
Why?
|
Treatment Failure | 3 | 2015 | 2648 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2009 | 2907 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12960 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1885 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22053 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11891 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9631 | 0.040 |
Why?
|
Vitamin D | 2 | 1992 | 3291 | 0.040 |
Why?
|
Forecasting | 1 | 2008 | 2932 | 0.040 |
Why?
|
Self Administration | 1 | 2000 | 390 | 0.040 |
Why?
|
Gene Expression Profiling | 4 | 2011 | 9411 | 0.040 |
Why?
|
Tilapia | 1 | 1998 | 24 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 2 | 2008 | 3387 | 0.040 |
Why?
|
Workplace | 1 | 2005 | 857 | 0.040 |
Why?
|
Urethral Obstruction | 1 | 2018 | 56 | 0.040 |
Why?
|
Camptothecin | 1 | 2022 | 590 | 0.040 |
Why?
|
Software | 3 | 2021 | 4419 | 0.040 |
Why?
|
Protein Transport | 2 | 2018 | 1964 | 0.040 |
Why?
|
Prednisone | 1 | 2023 | 1565 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2018 | 4264 | 0.040 |
Why?
|
Social Environment | 1 | 2023 | 1022 | 0.040 |
Why?
|
Vancomycin | 1 | 2021 | 503 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2022 | 784 | 0.040 |
Why?
|
HeLa Cells | 2 | 2018 | 3105 | 0.040 |
Why?
|
Myelodysplastic Syndromes | 1 | 2008 | 1394 | 0.040 |
Why?
|
Dexamethasone | 1 | 2005 | 1927 | 0.040 |
Why?
|
Blood Glucose | 1 | 1992 | 6381 | 0.040 |
Why?
|
Health Facilities | 1 | 2022 | 578 | 0.040 |
Why?
|
Epinephrine | 1 | 2020 | 791 | 0.040 |
Why?
|
Skin Tests | 1 | 2019 | 637 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5791 | 0.030 |
Why?
|
Heart Failure | 1 | 2021 | 11847 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3775 | 0.030 |
Why?
|
Patient Selection | 1 | 2008 | 4283 | 0.030 |
Why?
|
Growth Hormone | 1 | 1998 | 568 | 0.030 |
Why?
|
Infant | 4 | 2022 | 36060 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 852 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2017 | 402 | 0.030 |
Why?
|
Adenoviridae | 2 | 2014 | 1084 | 0.030 |
Why?
|
Child, Preschool | 5 | 2020 | 42063 | 0.030 |
Why?
|
Transfection | 2 | 2017 | 5781 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1998 | 0.030 |
Why?
|
K562 Cells | 2 | 2008 | 640 | 0.030 |
Why?
|
Social Support | 1 | 2005 | 2145 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2008 | 4742 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 4550 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2023 | 4775 | 0.030 |
Why?
|
Primary Prevention | 1 | 2022 | 1207 | 0.030 |
Why?
|
Antigens, CD34 | 2 | 2008 | 653 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7593 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13630 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2017 | 956 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2014 | 6238 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2000 | 965 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2693 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2128 | 0.030 |
Why?
|
Radiography | 2 | 2014 | 6965 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1588 | 0.030 |
Why?
|
Freezing | 1 | 2013 | 306 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2019 | 1484 | 0.030 |
Why?
|
Learning | 1 | 2022 | 1739 | 0.030 |
Why?
|
Rib Fractures | 1 | 2014 | 128 | 0.030 |
Why?
|
Time | 1 | 2014 | 545 | 0.030 |
Why?
|
Integrases | 1 | 2014 | 516 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4611 | 0.030 |
Why?
|
Erythropoietin | 2 | 2008 | 720 | 0.020 |
Why?
|
Lentivirus | 1 | 2014 | 506 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2021 | 1527 | 0.020 |
Why?
|
Cells, Cultured | 4 | 2008 | 18957 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 1992 | 263 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3016 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 600 | 0.020 |
Why?
|
Transcription Factors | 1 | 2011 | 12103 | 0.020 |
Why?
|
Stents | 1 | 2023 | 3314 | 0.020 |
Why?
|
Radiology | 1 | 2024 | 2102 | 0.020 |
Why?
|
Mice, Nude | 1 | 2017 | 3607 | 0.020 |
Why?
|
Models, Genetic | 1 | 2020 | 3442 | 0.020 |
Why?
|
Histone Deacetylase 2 | 1 | 2010 | 72 | 0.020 |
Why?
|
Hospitalization | 1 | 2010 | 10790 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1881 | 0.020 |
Why?
|
Coronary Disease | 1 | 2005 | 5990 | 0.020 |
Why?
|
Computer Simulation | 2 | 2014 | 6218 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1613 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2011 | 401 | 0.020 |
Why?
|
Hemorrhage | 1 | 2002 | 3600 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 1992 | 1385 | 0.020 |
Why?
|
Histone Deacetylase 1 | 1 | 2010 | 134 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2011 | 428 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2021 | 1913 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2005 | 4446 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3817 | 0.020 |
Why?
|
Animals | 8 | 2018 | 167963 | 0.020 |
Why?
|
Belgium | 2 | 2005 | 118 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6771 | 0.020 |
Why?
|
Models, Biological | 3 | 2014 | 9467 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2000 | 2781 | 0.020 |
Why?
|
Nuclear Localization Signals | 1 | 2009 | 77 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1347 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 1992 | 1175 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2018 | 1710 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12427 | 0.020 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2014 | 733 | 0.020 |
Why?
|
Hospitals, Rural | 1 | 2010 | 175 | 0.020 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2008 | 52 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3880 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3663 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2010 | 499 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2014 | 5201 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 1989 | 339 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 875 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2008 | 79 | 0.020 |
Why?
|
Anthropometry | 1 | 2013 | 1348 | 0.020 |
Why?
|
Africa | 1 | 2010 | 705 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8482 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4925 | 0.020 |
Why?
|
Integrin beta3 | 1 | 2008 | 121 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2013 | 1257 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7064 | 0.020 |
Why?
|
Radon | 1 | 1989 | 84 | 0.020 |
Why?
|
Cell Lineage | 2 | 2008 | 2533 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5523 | 0.020 |
Why?
|
Carbohydrates | 1 | 1989 | 388 | 0.020 |
Why?
|
Child | 4 | 2023 | 79806 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2008 | 385 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1928 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2009 | 929 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2013 | 2651 | 0.020 |
Why?
|
Acetylation | 1 | 2009 | 1062 | 0.020 |
Why?
|
Thrombopoietin | 1 | 2008 | 226 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7588 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2803 | 0.020 |
Why?
|
Movement | 1 | 2013 | 1474 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1697 | 0.020 |
Why?
|
Mice | 4 | 2017 | 81208 | 0.020 |
Why?
|
Adolescent | 5 | 2018 | 87810 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 1989 | 836 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2014 | 3380 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4573 | 0.020 |
Why?
|
Stem Cell Factor | 1 | 2005 | 196 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2005 | 5870 | 0.010 |
Why?
|
Anticoagulants | 1 | 2000 | 4897 | 0.010 |
Why?
|
Biological Transport | 1 | 1989 | 2086 | 0.010 |
Why?
|
Lysine | 1 | 2009 | 1001 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2919 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2008 | 1529 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7343 | 0.010 |
Why?
|
Interleukin-3 | 1 | 2005 | 425 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2005 | 869 | 0.010 |
Why?
|
Luciferases | 1 | 2005 | 716 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 2008 | 1387 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2010 | 1375 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1997 | 4215 | 0.010 |
Why?
|
Hodgkin Disease | 1 | 2010 | 1378 | 0.010 |
Why?
|
Retroviridae | 1 | 2005 | 850 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9280 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2532 | 0.010 |
Why?
|
Adenoviridae Infections | 1 | 2002 | 93 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13308 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6180 | 0.010 |
Why?
|
Genetic Markers | 1 | 2008 | 2608 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2873 | 0.010 |
Why?
|
Energy Intake | 1 | 1989 | 2129 | 0.010 |
Why?
|
Busulfan | 1 | 2002 | 258 | 0.010 |
Why?
|
BK Virus | 1 | 2002 | 123 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 2002 | 292 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10756 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2008 | 2414 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3735 | 0.010 |
Why?
|
Tumor Virus Infections | 1 | 2002 | 438 | 0.010 |
Why?
|
Antifreeze Proteins | 1 | 1998 | 12 | 0.010 |
Why?
|
Salmon | 1 | 1998 | 34 | 0.010 |
Why?
|
Aquaculture | 1 | 1998 | 29 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17790 | 0.010 |
Why?
|
Metallothionein | 1 | 1998 | 61 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3465 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8469 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8035 | 0.010 |
Why?
|
Neurons | 1 | 2018 | 9426 | 0.010 |
Why?
|
International Normalized Ratio | 1 | 2000 | 386 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26181 | 0.010 |
Why?
|
Energy Metabolism | 1 | 1989 | 2869 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 2913 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5039 | 0.010 |
Why?
|
Child Development | 1 | 1989 | 2285 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2009 | 13451 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24123 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29749 | 0.010 |
Why?
|
Blood Pressure | 1 | 1992 | 8525 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 17624 | 0.010 |
Why?
|
Long-Term Care | 1 | 2000 | 632 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4122 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13314 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18137 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2005 | 2145 | 0.010 |
Why?
|
Fishes | 1 | 1998 | 601 | 0.010 |
Why?
|
Transplantation Conditioning | 1 | 2002 | 1588 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2011 | 7850 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2000 | 2061 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 9585 | 0.010 |
Why?
|
DNA Primers | 1 | 1998 | 2819 | 0.010 |
Why?
|
Environmental Exposure | 1 | 1989 | 4412 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23376 | 0.010 |
Why?
|
Homozygote | 1 | 1998 | 1788 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 1998 | 1553 | 0.010 |
Why?
|
Prevalence | 1 | 2010 | 15687 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1997 | 2116 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2010 | 5130 | 0.010 |
Why?
|
Stem Cells | 1 | 2005 | 3523 | 0.010 |
Why?
|
Decision Making | 1 | 2005 | 3925 | 0.010 |
Why?
|
Cell Line | 1 | 2005 | 15620 | 0.010 |
Why?
|
Glycoproteins | 1 | 1998 | 2208 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2000 | 2315 | 0.010 |
Why?
|
Papillomavirus Infections | 1 | 2002 | 1607 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14660 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22023 | 0.010 |
Why?
|
Colon | 1 | 1997 | 1788 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10446 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2002 | 4166 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2000 | 3448 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12446 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1998 | 5785 | 0.000 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 1989 | 547 | 0.000 |
Why?
|